Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 4904 Records) |
| Query Trace: Neoplasms and EGFR[original query] |
|---|
| Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report. Case reports in oncology 2023 11 16 (1): 1384-1389. Andrew Davis, Sophia Jarrar, Christine Ciun |
| CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients. Frontiers in pharmacology 2023 11 14 1222435. Teerapat Majam, Chonlaphat Sukasem, Thanyanan Reungwetwattana, Phichai Chansriwong, Chalirmporn Atasilp, Narumol Trachu, Thanaporn Thamrongjirapat, Rattanaporn Sukprasong, Jennis Meanwattha |
| Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinoma. Translational lung cancer research 2023 11 12 (10): 2001-2014. Tetsuya Isaka, Yohei Miyagi, Tomoyuki Yokose, Haruhiro Saito, Rika Kasajima, Kozue Watabe, Naoko Shigeta, Noritake Kikunishi, Shunsuke Shigefuku, Kotaro Murakami, Hiroyuki Adachi, Takuya Nagashima, Hiroyuki I |
| EGFR Mutated Non-Small Cell Lung Cancer Complicated by Cancer Associated Ischemic Stroke. Maedica 2023 11 18 (3): 515-518. Manato Taguchi, Takeshi Kawakami, Sachie Hasegawa, Shinichiro Okauchi, Gen Ohara, Hiroaki Satoh, Nubuyuki Hiza |
| Prognostic Significance of Pretreatment Plasma D-dimer Levels in EGFR-Positive Advanced Non-Small Cell Lung Cancer Patients Receiving Osimertinib: A Multicentre Retrospective Study. International journal of general medicine 2023 11 16 5481-5491. Qianfei Liu, Liping Tan, Jianbo He, Ruiling Ning, Aiping Zeng, Yilin Ch |
| Clinical implications of PNA?sequencing as a complementary test for EGFR mutation analysis in human lung cancer. Oncology letters 2023 11 26 (6): 539. Yi-Lin Chen, Chien-Chung Lin, Yu-Ting Yu, Wan-Li Chen, Shu-Ching Yang, Wenya Huang, Wu-Chou Su, Nan-Haw Chow, Chung-Liang |
| The oncogenic role of LGR6 overexpression induced by aberrant Wnt/?-catenin signaling in lung cancer. Thoracic cancer 2023 11 . Noriaki Sunaga, Kyoichi Kaira, Kimihiro Shimizu, Ichidai Tanaka, Yosuke Miura, Seshiru Nakazawa, Yoichi Ohtaki, Reika Kawabata-Iwakawa, Mitsuo Sato, Luc Girard, John D Minna, Takeshi Hisa |
| BRIEF REPORT: Real-world efficacy and safety of amivantamab for EGFR-mutant non-small cell lung cancer (NSCLC). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 11 . Kaiwen Wang, Robyn Du, Nathaniel J Myall, Whitney E Lewis, Natalie Uy, Lingzhi Hong, Ferdinandos Skoulidis, Lauren A Byers, Anne Tsao, Tina Cascone, Jenny Pozadzides, Janet Tu, Marcelo V Negrao, Don L Gibbons, Keunchil Park, Waree Rinsurongkawong, J Jack Lee, David Gandara, Deepti Behl, Catherine A Shu, Jonathan W Riess, Christina Baik, Heather A Wakelee, Ara A Vaporciyan, John V Heymach, Jianjun Zhang, Xiuning |
| Study on Targeted Drugs for Non-Small Cell NSCLC with PD-1PD-L1 Signaling Pathway. Studies in health technology and informatics 2023 11 308 562-567. Xinran C |
| Detection of EGFR gene polymorphisms in non-small cell lung cancer Egyptian patients: a case-control study. Genes and environment : the official journal of the Japanese Environmental Mutagen Society 2023 11 45 (1): 32. Omali Y El-Khawaga, Mohammed F Al-Azzawy, Afaf M ElSaid, Sherif Refaat, Aliaa N El-Da |
| Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors. Translational oncology 2023 11 39 101834. Zhiqin Lu, Yali Yi, Linxiao Wang, Yuxi Luo, Daya Luo, Le Xiong, Yun Shu, Hui Luo, Jing Li, Wufu Zhu, Zhimin Zeng, Anwen L |
| Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations. Cancers 2023 11 15 (22): . Soojin Jun, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Juhee Cho, Hyun Ae Ju |
| Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations. Cancers 2023 11 15 (22): . Petros Christopoulos, Nicolas Girard, Claudia Proto, Marta Soares, Pilar Garrido Lopez, Anthonie J van der Wekken, Sanjay Popat, Joris Diels, Claudio A Schioppa, Jan Sermon, Nora Rahhali, Corinna Pick-Lauer, Agnieszka Adamczyk, James Penton, Marie Wisl |
| Prognostic Outcomes and Recurrence Patterns in Resected Stage I Lung Adenocarcinoma Harboring Atypical Epidermal Growth Factor Receptor Mutation. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2023 11 . Tao Chen, Jialiang Wen, Yingze Li, Jiajun Deng, Yifan Zhong, Likun Hou, Yunlang She, Dong Xie, Chang Ch |
| Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion. Current oncology (Toronto, Ont.) 2023 11 30 (11): 9929-9939. Yue Zheng, Yang Fu, Yueyun Chen, Qing Li, Ting Liu, Zhenyu Di |
| Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01). Japanese journal of clinical oncology 2023 11 . Kiyoaki Uryu, Yoshinori Imamura, Rai Shimoyama, Takahiro Mase, Yoshiaki Fujimura, Maki Hayashi, Megu Ohtaki, Keiko Otani, Makoto Hibino, Shigeto Horiuchi, Tomoya Fukui, Ryuta Fukai, Yusuke Chihara, Akihiko Iwase, Noriko Yamada, Yukihiro Tamura, Hiromasa Harada, Nobuaki Shinozaki, Asuka Tsuya, Masahiro Fukuoka, Hironobu Mina |
| Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP). Lung cancer (Amsterdam, Netherlands) 2023 11 186 107426. Yoshihiko Sakata, Go Saito, Shinya Sakata, Yuko Oya, Motohiro Tamiya, Hidekazu Suzuki, Ryota Shibaki, Asuka Okada, Toshihide Yokoyama, Hirotaka Matsumoto, Taiichiro Otsuki, Yuki Sato, Uchida Junji, Yoko Tsukita, Megumi Inaba, Hideki Ikeda, Daisuke Arai, Hirotaka Maruyama, Satoshi Hara, Shinsuke Tsumura, Jun Morinaga, Takuro Sakaga |
| Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer. Cancer research and treatment 2023 11 . Patinya Akkhasutthikun, Pornchai Kaewsapsak, Pattaraporn Nimsamer, Pavit Klomkliew, Suthida Visedthorn, Pragwalai Chanchaem, Chinachote Teerapakpinyo, Sunchai Payungporn, Sutima Luangdil |
| Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC. Scientific reports 2023 11 13 (1): 20323. Jia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, Chi-Hsien Huang, Tzu-Hsuan Chiu, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Ya |
| Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
| Allelic context of EGFR C797X mutant lung cancer defines four subtypes with heterogeneous genomic landscape and distinct clinical outcomes. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 11 . Chang Lu, Xue-Wu Wei, Zhen Wang, Zhen Zhou, Yu-Tao Liu, Di Zheng, Yong He, Zhan-Hong Xie, Yong Li, Yan Zhang, Yi-Chen Zhang, Zi-Jian Huang, Shi-Qi Mei, Jia-Qi Liu, Xu-Hui Guan, Yu Deng, Zhi-Hong Chen, Hai-Yan Tu, Chong-Rui Xu, Hua-Jun Chen, Wen-Zhao Zhong, Jin-Ji Yang, Xu-Chao Zhang, Tony S K Mok, Yi-Long Wu, Qing Zh |
| Pan-tumor analytical validation and osimertinib clinical validation in EGFR mutant non-small cell lung cancer, supporting the first next generation sequencing liquid biopsy in vitro diagnostic. The Journal of molecular diagnostics : JMD 2023 11 . Jhanelle E Gray, Ji-Youn Han, Aino Telaranta-Keerie, Xiangning Huang, Alexander Kohlmann, Rachel Hodge, Yuri Rukazenkov, Juliann Chmielecki, Carin R Espenschied, Martina Lefterova, Yi-Long Wu, Suresh S Ramalingam, J Carl Barrett, Justin I Odegaa |
| Air bronchogram on chest CT in radiological pure-solid appearance lung cancer: Correlation analysis with genetic pathological features and survival outcomes. European journal of radiology 2023 11 169 111194. Zijian Wang, Wei Zhu, Menghang Yang, He Du, Fei Zhou, Nan Song, Ziwei Wan, Jingqi Zhu, Wei |
| Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
| Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images. Physics in medicine and biology 2023 11 . Jing Gong, Fangqiu Fu, Xiaowen Ma, Ting Wang, Xiangyi Ma, Chao You, Yang Zhang, Weijun Peng, Haiquan Chen, Yajia |
| Association between cigarette smoking history, metabolic phenotypes, and EGFR mutation status in patients with non-small cell lung cancer. Journal of thoracic disease 2023 11 15 (10): 5689-5699. Xiaohui Zhang, Xiuyu Guo, Qiaoling Gao, Jingfeng Zhang, Jianjun Zheng, Guofang Zhao, Katsuhiro Okuda, Alfredo Tartarone, Maoqing Jia |
| Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study. Journal of thoracic disease 2023 11 15 (10): 5648-5657. Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying |
| Effect of pre-treatment of EGFR-TKIs on immune checkpoint inhibitor-associated interstitial lung disease in lung cancer patients: Analysis using a Japanese claims database. International journal of clinical pharmacology and therapeutics 2023 11 . Naoto Okada, Hirofumi Hamano, Kenta Yagi, Takahiro Niimura, Fuka Aizawa, Mitsuhiro Goda, Yoshito Zamami, Takashi Kitahara, Keisuke Ishiza |
| Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in Lung Cancer: Idylla versus Digital Droplet PCR. International journal of molecular sciences 2023 11 24 (21): . Camille Léonce, Clémence Guerriau, Lara Chalabreysse, Michaël Duruisseaux, Sébastien Couraud, Marie Brevet, Pierre-Paul Bringuier, Delphine Aude Ponc |
| Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer. Scientific reports 2023 11 13 (1): 19729. Takeshi Masuda, Satoru Miura, Yuki Sato, Motoko Tachihara, Akihiro Bessho, Atsushi Nakamura, Taichi Miyawaki, Kohei Yoshimine, Masahide Mori, Hideaki Shiraishi, Kosuke Hamai, Koji Haratani, Sumiko Maeda, Eriko Tabata, Chiyoe Kitagawa, Junko Tanizaki, Takumi Imai, Shohei Nogami, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Noboru Hatto |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: